Dexcom (DXCM) Free Cash Flow (2010 - 2026)

Dexcom (DXCM) has 17 years of Free Cash Flow data on file, last reported at $449.0 million in Q1 2026.

• On a quarterly basis, Free Cash Flow rose 363.84% year-over-year to $449.0 million in Q1 2026; TTM through Mar 2026 was $1.4 billion, a 148.5% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 70.79% from the prior year.
• Free Cash Flow for Q1 2026 stood at $449.0 million, up from $192.1 million in the prior quarter.
• Over the last five years, Free Cash Flow for DXCM reached as high as $579.4 million in Q3 2025 and fell as low as -$30.6 million in Q1 2022.
• Historically, Free Cash Flow has averaged $174.9 million across 5 years, with a median of $152.3 million in 2024.
• Across the five-year window, Free Cash Flow sank 59.64% in 2024 and surged 556.17% in 2025, its largest moves.
• Year by year, Free Cash Flow stood at $69.0 million in 2022, then advanced by 17.54% to $81.1 million in 2023, then soared by 118.0% to $176.8 million in 2024, then climbed by 8.65% to $192.1 million in 2025, then surged by 133.73% to $449.0 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were $449.0 million in Q1 2026, $192.1 million in Q4 2025, and $579.4 million in Q3 2025.